97 related articles for article (PubMed ID: 27453342)
1. Transcriptional regulation of BMCC1 mediated by E2F1 in neuroblastoma cells.
Islam MS; Tatsumi Y; Takano R; Yokochi T; Akter J; Ozaki T; Nakamura Y; Ohira M; Nakagawara A
Biochem Biophys Res Commun; 2016 Sep; 478(1):81-86. PubMed ID: 27453342
[TBL] [Abstract][Full Text] [Related]
2. Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells.
Islam MS; Takano R; Yokochi T; Akter J; Nakamura Y; Nakagawara A; Tatsumi Y
BMC Cancer; 2019 Jun; 19(1):542. PubMed ID: 31170959
[TBL] [Abstract][Full Text] [Related]
3. BMCC1, which is an interacting partner of BCL2, attenuates AKT activity, accompanied by apoptosis.
Tatsumi Y; Takano R; Islam MS; Yokochi T; Itami M; Nakamura Y; Nakagawara A
Cell Death Dis; 2015 Jan; 6(1):e1607. PubMed ID: 25611382
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas.
Machida T; Fujita T; Ooo ML; Ohira M; Isogai E; Mihara M; Hirato J; Tomotsune D; Hirata T; Fujimori M; Adachi W; Nakagawara A
Oncogene; 2006 Mar; 25(13):1931-42. PubMed ID: 16288218
[TBL] [Abstract][Full Text] [Related]
5. microRNA‑202 suppresses MYCN expression under the control of E2F1 in the neuroblastoma cell line LAN‑5.
Li YG; He JH; Yu L; Hang ZP; Li W; Shun WH; Huang GX
Mol Med Rep; 2014 Feb; 9(2):541-6. PubMed ID: 24337320
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma.
Muth D; Ghazaryan S; Eckerle I; Beckett E; Pöhler C; Batzler J; Beisel C; Gogolin S; Fischer M; Henrich KO; Ehemann V; Gillespie P; Schwab M; Westermann F
Cancer Res; 2010 May; 70(9):3791-802. PubMed ID: 20424123
[TBL] [Abstract][Full Text] [Related]
7. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
8. Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma.
Eckerle I; Muth D; Batzler J; Henrich KO; Lutz W; Fischer M; Witt O; Schwab M; Westermann F
Cancer Lett; 2009 Nov; 285(1):99-107. PubMed ID: 19497660
[TBL] [Abstract][Full Text] [Related]
9. The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73.
Peirce SK; Findley HW
Int J Oncol; 2009 May; 34(5):1395-402. PubMed ID: 19360352
[TBL] [Abstract][Full Text] [Related]
10. RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation.
Feldstein O; Ben-Hamo R; Bashari D; Efroni S; Ginsberg D
Mol Cancer Res; 2012 Sep; 10(9):1169-77. PubMed ID: 22798430
[TBL] [Abstract][Full Text] [Related]
11. PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis.
Liu X; Cai Y; Cheng C; Gu Y; Hu X; Chen K; Wu Y; Wu Z
Cell Death Dis; 2022 Feb; 13(2):178. PubMed ID: 35210406
[TBL] [Abstract][Full Text] [Related]
12. Dependence receptor UNC5D mediates nerve growth factor depletion-induced neuroblastoma regression.
Zhu Y; Li Y; Haraguchi S; Yu M; Ohira M; Ozaki T; Nakagawa A; Ushijima T; Isogai E; Koseki H; Nakamura Y; Kong C; Mehlen P; Arakawa H; Nakagawara A
J Clin Invest; 2013 Jul; 123(7):2935-47. PubMed ID: 23778138
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
Schayek H; Bentov I; Rotem I; Pasmanik-Chor M; Ginsberg D; Plymate SR; Werner H
Growth Horm IGF Res; 2010 Feb; 20(1):68-72. PubMed ID: 19703789
[TBL] [Abstract][Full Text] [Related]
14. BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas.
Nowak K; Kerl K; Fehr D; Kramps C; Gessner C; Killmer K; Samans B; Berwanger B; Christiansen H; Lutz W
Nucleic Acids Res; 2006; 34(6):1745-54. PubMed ID: 16582100
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the G1/S transition phase in mesangial cells by E2F1.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Oct; 56(4):1238-41. PubMed ID: 10504464
[TBL] [Abstract][Full Text] [Related]
16. Roles of E2F1 in mesangial cell proliferation in vitro.
Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
[TBL] [Abstract][Full Text] [Related]
17. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
19. Alien inhibits E2F1 gene expression and cell proliferation.
Tenbaum SP; Papaioannou M; Reeb CA; Goeman F; Escher N; Kob R; von Eggeling F; Melle C; Baniahmad A
Biochim Biophys Acta; 2007 Sep; 1773(9):1447-54. PubMed ID: 17570542
[TBL] [Abstract][Full Text] [Related]
20. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
Ofir M; Hacohen D; Ginsberg D
Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
